Loading...

Please wait

Podcast

Loading...

OndaCast© 2026 OndaCast. All rights reserved.

Help Contact Terms Privacy Copyright DMCA About Radio Guide Embed Player

Waves Explore Library Vibes Podcasts Audiobooks

The Biotech Startups Podcast - Podcast | OndaCast

Podcast

Back to Podcasts

The Biotech Startups Podcast

Podcast ShowPodcasten

The Biotech Startups Podcast

The Biotech Startups Podcast by Excedr features weekly conversations with founders, scientists, and investors driving biotech innovation. Host Jon Chee dives into the challenges of building biotech startups, from pre-seed to IPO. New episodes every Monday and Thursday.

200 episodes•0 subscribers•0 Total Listens

Episode Playlist

50 episodes

🧬 Biotech Investing Unlocked: Mindset Shift, Risk, and Founder-First Lessons | Johnny Hu (Part 3/4)

Jun 2, 2025•—

🧬 Biotech Investing Unlocked: Mindset Shift, Risk, and Founder-First Lessons | Johnny Hu (Part 3/4)

🧬 AI, Mentors & the Future of Biotech: Teambuilding, Investing, & Innovation | Johnny Hu (Part 4/4)

Jun 5, 2025•—

🧬 AI, Mentors & the Future of Biotech: Teambuilding, Investing, & Innovation | Johnny Hu (Part 4/4)

🧬 Passion Is Chaos: Grit, Curiosity, & the Biotech Breakthrough Mindset | Ivan Liachko (Part 1/4)

Jun 9, 2025•—

🧬 Passion Is Chaos: Grit, Curiosity, & the Biotech Breakthrough Mindset | Ivan Liachko (Part 1/4)

🧬 Startup Survival Skills: Resilience, Frugality & Real Talk in Biotech | Ivan Liachko (Part 2/4)

Jun 18, 2025•—

🧬 Startup Survival Skills: Resilience, Frugality & Real Talk in Biotech | Ivan Liachko (Part 2/4)

🧬 How 3D Genome Mapping is Changing Everything We Know About DNA | Ivan Liachko (Part 3/4)

Jun 25, 2025•—

🧬 How 3D Genome Mapping is Changing Everything We Know About DNA | Ivan Liachko (Part 3/4)

🧬 Growth Without Venture Capital: The Bootstrapped Bioscience Playbook | Ivan Liachko (Part 4/4)

Jul 2, 2025•—

🧬 Growth Without Venture Capital: The Bootstrapped Bioscience Playbook | Ivan Liachko (Part 4/4)

🧬 Embracing Identity & Curiosity: Being Different Fuels Innovation | Aaron Edwards (Part 1/4)

Jul 9, 2025•—

🧬 Embracing Identity & Curiosity: Being Different Fuels Innovation | Aaron Edwards (Part 1/4)

🧬 Why Most Biotech Startups Fail (And How to Survive Market Crashes) | Aaron Edwards (Part 2/4)

Jul 16, 2025•—

🧬 Why Most Biotech Startups Fail (And How to Survive Market Crashes) | Aaron Edwards (Part 2/4)

🧬 Non-Traditional Leadership & Knowledge Sharing: The New Edge in Biotech | Aaron Edwards (Part 3/4)

Jul 23, 2025•—

🧬 Non-Traditional Leadership & Knowledge Sharing: The New Edge in Biotech | Aaron Edwards (Part 3/4)

🧬 Multi-Edit CAR T-Cells: The Crazy Science That Might Cure Brain Cancer | Aaron Edwards (Part 4/4)

Jul 30, 2025•—

🧬 Multi-Edit CAR T-Cells: The Crazy Science That Might Cure Brain Cancer | Aaron Edwards (Part 4/4)

🧬 Boy Scout Values & Refugee Resilience: Building Biotech Leadership | Samir Khleif (Part 1/4)

Aug 4, 2025•—

🧬 Boy Scout Values & Refugee Resilience: Building Biotech Leadership | Samir Khleif (Part 1/4)

🧬 Breaking the Wall Between Science & Patient Care: Translational Medicine | Samir Khleif (Part 2/4)

Aug 7, 2025•—

🧬 Breaking the Wall Between Science & Patient Care: Translational Medicine | Samir Khleif (Part 2/4)

🧬How One Leader United 120 Experts to Transform Cancer Care | Samir Khleif (Part 3/4)

Aug 11, 2025•—

🧬How One Leader United 120 Experts to Transform Cancer Care | Samir Khleif (Part 3/4)

🧬Surviving the Biotech Funding Crunch: Insider Strategies | Samir Khleif (Part 4/4)

Aug 14, 2025•—

🧬Surviving the Biotech Funding Crunch: Insider Strategies | Samir Khleif (Part 4/4)

🧬The Diamond of Success: 4 Traits Every Leader Needs | Michael Newton (Part 1/4)

Aug 18, 2025•—

🧬The Diamond of Success: 4 Traits Every Leader Needs | Michael Newton (Part 1/4)

🧬Why One-Size-Fits-All Leadership Fails - How Context Creates Success | Michael Newton (Part 2/4)

Aug 21, 2025•—

🧬Why One-Size-Fits-All Leadership Fails - How Context Creates Success | Michael Newton (Part 2/4)

🧬 How We Scaled Nike Innovation from the Shoelace Room | Michael Newton (Part 3/4)

Aug 25, 2025•—

🧬 How We Scaled Nike Innovation from the Shoelace Room | Michael Newton (Part 3/4)

🧬Reinventing Leather: How SynBio Is Transforming a $100B Industry | Michael Newton (Part 4/4)

Aug 28, 2025•—

🧬Reinventing Leather: How SynBio Is Transforming a $100B Industry | Michael Newton (Part 4/4)

Cultural Adaptation: A Secret Weapon for Biotech Success | Eswar Iyer (Part 1/4)

Sep 1, 2025•—

Cultural Adaptation: A Secret Weapon for Biotech Success | Eswar Iyer (Part 1/4)

🧬 Breaking Moore's Law: The Multiplexing Revolution | Eswar Iyer (Part 2/4)

Sep 4, 2025•—

🧬 Breaking Moore's Law: The Multiplexing Revolution | Eswar Iyer (Part 2/4)

🧬 Innovation & IP Strategy: The Blueprint for Success in Biotech | Eswar Iyer (Part 3/4)

Sep 8, 2025•—

🧬 Innovation & IP Strategy: The Blueprint for Success in Biotech | Eswar Iyer (Part 3/4)

🧬 The Hidden Advantages of Starting Up in a Downturn | Eswar Iyer (Part 4/4)

Sep 11, 2025•—

🧬 The Hidden Advantages of Starting Up in a Downturn | Eswar Iyer (Part 4/4)

🧬 How to Build a Startup When Everything is Against You | Andrey Doronichev (Part 1/4)

Sep 15, 2025•—

🧬 How to Build a Startup When Everything is Against You | Andrey Doronichev (Part 1/4)

🧬 How I Turned Economic Chaos Into My Biggest Advantage | Andrey Doronichev (Part 2/4)

Sep 18, 2025•—

🧬 How I Turned Economic Chaos Into My Biggest Advantage | Andrey Doronichev (Part 2/4)

🧬 Inside the Google vs. Apple War: Launching YouTube iOS | Andrey Doronichev (Part 3/4)

Sep 22, 2025•—

🧬 Inside the Google vs. Apple War: Launching YouTube iOS | Andrey Doronichev (Part 3/4)

🧬 Why Drug Discovery Takes 15 Years (And How AI Cuts It to 3) | Andrey Doronichev (Part 4/4)

Sep 25, 2025•—

🧬 Why Drug Discovery Takes 15 Years (And How AI Cuts It to 3) | Andrey Doronichev (Part 4/4)

🧬 How Trauma Informs Purpose: Building Biotech Success | Sandra Shpilberg (Part 1/4)

Sep 29, 2025•—

🧬 How Trauma Informs Purpose: Building Biotech Success | Sandra Shpilberg (Part 1/4)

🧬 The $3B Patient Recruitment Crisis: Digital Solutions | Sandra Shpilberg (Part 2/4)

Oct 2, 2025•—

🧬 The $3B Patient Recruitment Crisis: Digital Solutions | Sandra Shpilberg (Part 2/4)

🧬 No VC, No Problem: Building a Profitable Exit | Sandra Shpilberg (Part 3/4)

Oct 6, 2025•—

🧬 No VC, No Problem: Building a Profitable Exit | Sandra Shpilberg (Part 3/4)

🧬 How to Build Your Circle When You're Starting From Zero | Sandra Shpilberg (Part 4/4)

Oct 9, 2025•—

🧬 How to Build Your Circle When You're Starting From Zero | Sandra Shpilberg (Part 4/4)

🧬 Building Berkeley's $1B Innovation Ecosystem | Darren Cooke (Part 1/4)

Oct 13, 2025•—

🧬 Building Berkeley's $1B Innovation Ecosystem | Darren Cooke (Part 1/4)

🧬 Mentors, Networks & IP: Power Moves for Biotech Startup Success | Darren Cooke (Part 2/4)

Oct 16, 2025•—

🧬 Mentors, Networks & IP: Power Moves for Biotech Startup Success | Darren Cooke (Part 2/4)

🧬 How to Turn Regulatory Chaos Into Competitive Advantage | Darren Cooke (Part 3/4)

Oct 20, 2025•—

🧬 How to Turn Regulatory Chaos Into Competitive Advantage | Darren Cooke (Part 3/4)

🧬 100 Discovery Interviews Built a $3M Biotech Launchpad at Berkeley | Darren Cooke (Part 4/4)

Oct 23, 2025•—

🧬 100 Discovery Interviews Built a $3M Biotech Launchpad at Berkeley | Darren Cooke (Part 4/4)

🧬 The Rebellious Mindset That Builds Successful Startups | Jimmy Sastra (Part 1/4)

Oct 27, 2025•—

🧬 The Rebellious Mindset That Builds Successful Startups | Jimmy Sastra (Part 1/4)

🧬 Lessons From Building the World's First Robotic Cloud Lab | Jimmy Sastra (Part 2/4)

Oct 30, 2025•—

🧬 Lessons From Building the World's First Robotic Cloud Lab | Jimmy Sastra (Part 2/4)

🧬 Autonomous Labs: The Future of Cell Culture | Jimmy Sastra (Part 3/4)

Nov 3, 2025•—

🧬 Autonomous Labs: The Future of Cell Culture | Jimmy Sastra (Part 3/4)

🧬 How Autonomous Science Will Change Drug Discovery Forever | Jimmy Sastra (Part 4/4)

Nov 6, 2025•—

🧬 How Autonomous Science Will Change Drug Discovery Forever | Jimmy Sastra (Part 4/4)

🧬 Childhood Without Tech: Building a Foundation for VC Success | Sergey Jakimov (1/4)

Nov 10, 2025•—

🧬 Childhood Without Tech: Building a Foundation for VC Success | Sergey Jakimov (1/4)

🧬 The Bank Heist Model: How to Build Your Startup Team | Sergey Jakimov (2/4)

Nov 13, 2025•—

🧬 The Bank Heist Model: How to Build Your Startup Team | Sergey Jakimov (2/4)

🧬 $25M Fund, 20 Companies, Zero Failures: A Biotech Investing Secret | Sergey Jakimov (3/4)

Nov 17, 2025•—

🧬 $25M Fund, 20 Companies, Zero Failures: A Biotech Investing Secret | Sergey Jakimov (3/4)

🧬 Big Pharma's $180B Patent Cliff: Why VCs Are Betting on Biotech | Sergey Jakimov (4/4)

Nov 20, 2025•—

🧬 Big Pharma's $180B Patent Cliff: Why VCs Are Betting on Biotech | Sergey Jakimov (4/4)

🧬 How Biotech Companies Get Debt Funding (Without Revenue) | Parag Shah Re-Release (1/2)

Nov 24, 2025•—

🧬 How Biotech Companies Get Debt Funding (Without Revenue) | Parag Shah Re-Release (1/2)

🧬 Profit + Purpose: The New Model for Healthcare Investing | Parag Shah Re-Release (2/2)

Nov 27, 2025•—

🧬 Profit + Purpose: The New Model for Healthcare Investing | Parag Shah Re-Release (2/2)

🧬 Working 3 Jobs at Harvard: How Desperation Built Conviction | Krish Ramadurai (1/4)

Dec 1, 2025•—

🧬 Working 3 Jobs at Harvard: How Desperation Built Conviction | Krish Ramadurai (1/4)

🧬 Why 40% of Venture Funds Failed Last Year (And How to Avoid It) | Krish Ramadurai (2/4)

Dec 4, 2025•—

🧬 Why 40% of Venture Funds Failed Last Year (And How to Avoid It) | Krish Ramadurai (2/4)

🧬 Controlled Chaos: Why Success Isn't Planned (And Doesn't Need To Be) | Krish Ramadurai (3/4)

Dec 8, 2025•—

🧬 Controlled Chaos: Why Success Isn't Planned (And Doesn't Need To Be) | Krish Ramadurai (3/4)

🧬 Seed Rounds Are the New Series A: How Funding Benchmarks Shifted | Krish Ramadurai (4/4)

Dec 11, 2025•—

🧬 Seed Rounds Are the New Series A: How Funding Benchmarks Shifted | Krish Ramadurai (4/4)

🧬 The Mayan Negotiation Secret That Built A Biotech Company | Jake Glanville Re-Release (1/4)

Dec 15, 2025•—

🧬 The Mayan Negotiation Secret That Built A Biotech Company | Jake Glanville Re-Release (1/4)

🧬 From Raw Data to Better Drugs: Deep Sequencing Antibodies | Jake Glanville Re-Release (2/4)

Dec 18, 2025•—

🧬 From Raw Data to Better Drugs: Deep Sequencing Antibodies | Jake Glanville Re-Release (2/4)

You May Also Like

OndaCast© 2026 OndaCast. All rights reserved.

Help Contact Terms Privacy Copyright DMCA About Radio Guide Embed Player

Waves Explore Library Vibes Podcasts Audiobooks